Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Exchange Rates
Interest Rates
Futures
Economy
Global Metrics

CytRx - 30 Year Stock Price History | CYTR

Historical daily share price chart and data for CytRx since 1989 adjusted for splits. The latest closing stock price for CytRx as of June 03, 2019 is 0.31.
  • The all-time high CytRx stock closing price was 1868.91 on January 15, 1992.
  • The CytRx 52-week high stock price is 0.78, which is 151.6% above the current share price.
  • The CytRx 52-week low stock price is 0.30, which is 3.2% below the current share price.
  • The average CytRx stock price for the last 52 weeks is 0.58.
  
CytRx Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
2019 0.6009 0.5150 0.7601 0.3100 0.3100 -30.93%
2018 1.2648 1.7500 2.2700 0.3600 0.4488 -73.44%
2017 2.8498 2.3161 5.7978 1.6900 1.6900 -24.31%
2016 9.4273 15.3569 20.9358 2.2328 2.2328 -85.95%
2015 19.4153 16.6767 31.6137 12.1776 15.8968 -3.28%
2014 23.2619 41.3917 48.4703 12.8974 16.4367 -56.30%
2013 15.3510 11.2777 37.6125 11.2178 37.6125 235.29%
2012 18.3395 11.1370 32.5735 9.7780 11.2178 -4.56%
2011 26.1511 44.0780 44.0780 10.7088 11.7541 -72.28%
2010 41.0430 45.3373 59.1904 27.7061 42.3988 -9.82%
2009 30.9073 12.5895 54.1529 10.0834 47.0165 273.33%
2008 38.5034 109.9850 109.9850 10.4948 12.5937 -89.44%
2007 152.6642 78.9205 216.1919 75.5622 119.2204 48.69%
2006 61.1262 42.8186 94.0330 39.4603 80.1799 85.44%
2005 44.0439 57.9310 73.0435 31.9040 43.2384 -26.43%
2004 62.7751 80.1799 94.4528 39.4603 58.7706 -24.73%
2003 67.9740 11.3343 132.2339 9.6552 78.0810 644.00%
2002 24.6686 27.2864 44.0780 9.2354 10.4948 -61.54%
2001 36.6581 34.1079 49.5352 21.8291 27.2864 -9.57%
2000 62.9122 44.4977 262.3688 23.5082 30.1745 -20.69%
1999 101.6528 44.6237 141.6792 34.1079 38.0456 -6.45%
1998 84.5883 141.6792 152.1739 31.4843 40.6693 -67.03%
1997 168.7556 139.0765 236.1319 123.3343 123.3343 -14.59%
1996 179.1622 199.8201 241.3793 138.9505 144.4078 -23.56%
1995 323.8014 230.8845 524.7376 152.1319 188.9055 -14.32%
1994 749.6018 1049.4752 1322.3388 215.1004 220.4737 -78.99%
1993 834.3164 902.5487 1165.0014 566.7166 1049.4752 19.05%
1992 1015.8087 1007.4962 1868.9054 587.7061 881.5592 -11.59%
1991 419.7196 136.4318 1081.0434 136.4318 997.0854 660.02%
1990 333.0342 320.0480 598.2848 131.1928 131.1928 -54.58%
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $0.008B $0.000B
CYTRX CORP. is engaged in the development and commercialization of pharmaceutical related products and services including human therapeutics focused on high-value critical- care therapies.
Stock Name Country Market Cap PE Ratio
Amgen (AMGN) United States $138.902B 16.00
CSL (CSLLY) Australia $87.394B 0.00
Gilead Sciences (GILD) United States $84.866B 10.51
Vertex Pharmaceuticals (VRTX) United States $57.409B 58.60
Biogen (BIIB) United States $54.179B 9.30
Illumina (ILMN) United States $47.991B 52.66
Regeneron Pharmaceuticals (REGN) United States $40.872B 17.90
Alexion Pharmaceuticals (ALXN) United States $25.203B 12.45
Incyte (INCY) United States $20.351B 47.24
Seattle Genetics (SGEN) United States $20.138B 0.00
SINO PHARMACEUT (SBMFF) Hong Kong, SAR China $17.624B 0.00
Genmab (GNMSF) Denmark $14.761B 65.20
BioMarin Pharmaceutical (BMRN) United States $14.356B 0.00
Alnylam Pharmaceuticals (ALNY) United States $13.798B 0.00
Galapagos (GLPG) Belgium $11.704B 30.16
Exact Sciences (EXAS) United States $11.197B 0.00
Bio-Rad Laboratories (BIO.B) United States $10.393B 49.88
QIAGEN (QGEN) Netherlands $9.429B 30.74
BeiGene (BGNE) Cayman Islands $8.976B 0.00
Bio-Techne Corp (TECH) United States $8.358B 55.95
Sarepta Therapeutics (SRPT) United States $8.159B 0.00
Amarin (AMRN) Ireland $8.019B 0.00
ACADIA Pharmaceuticals (ACAD) United States $7.917B 0.00
Guardant Health (GH) United States $6.947B 0.00
Medicines (MDCO) United States $6.714B 0.00
Moderna (MRNA) United States $6.312B 0.00
Horizon Therapeutics Public (HZNP) Ireland $6.037B 15.35
Reata Pharmaceuticals (RETA) United States $6.034B 0.00
ARGENX SE-ADR (ARGX) Netherlands $5.618B 0.00
BioNTech SE (BNTX) Germany $5.514B 0.00
Exelixis (EXEL) United States $5.275B 14.84
Repligen (RGEN) United States $4.701B 85.19
China Biologic Products (CBPO) China $4.603B 25.93
Ascendis Pharma (ASND) Denmark $4.532B 0.00
Bluebird Bio (BLUE) United States $4.394B 0.00
Spark Therapeutics (ONCE) United States $4.263B 0.00
MorphoSys AG (MOR) Germany $4.153B 0.00
Mirati Therapeutics (MRTX) United States $4.047B 0.00
CRISPR Therapeutics AG (CRSP) Switzerland $3.995B 0.00
Immunomedics (IMMU) United States $3.981B 0.00
Blueprint Medicines (BPMC) United States $3.861B 0.00
Adaptive Biotechnologies (ADPT) United States $3.613B 0.00
Intercept Pharmaceuticals (ICPT) United States $3.518B 0.00
Alkermes (ALKS) Ireland $3.300B 0.00
MyoKardia (MYOK) United States $3.117B 0.00
Genmab (GMAB) Denmark $3.064B 6.31
UniQure (QURE) Netherlands $2.881B 0.00
Emergent Biosolutions (EBS) United States $2.838B 28.19
Halozyme Therapeutics (HALO) United States $2.808B 0.00
NeoGenomics (NEO) United States $2.779B 147.89
Acceleron Pharma (XLRN) United States $2.648B 0.00
Amicus Therapeutics (FOLD) United States $2.576B 0.00
Ultragenyx Pharmaceutical (RARE) United States $2.484B 0.00
Arena Pharmaceuticals (ARNA) United States $2.408B 5.60
Zai Lab (ZLAB) China $2.399B 0.00
RA PHARMCTL INC (RARX) United States $2.216B 0.00
Insmed (INSM) United States $2.064B 0.00
Myriad Genetics (MYGN) United States $1.905B 28.14
Ligand Pharmaceuticals (LGND) United States $1.897B 36.49
Dicerna Pharmaceuticals (DRNA) United States $1.822B 0.00
Momenta Pharmaceuticals (MNTA) United States $1.782B 0.00
Denali Therapeutics (DNLI) United States $1.754B 0.00
Epizyme (EPZM) United States $1.659B 0.00
Akcea Therapeutics (AKCA) United States $1.656B 0.00
Zymeworks (ZYME) Canada $1.648B 0.00
REGENXBIO (RGNX) United States $1.647B 0.00
Editas Medicine (EDIT) United States $1.586B 0.00
Nabriva Therapeutics AG (NBRV) Ireland $1.402B 0.00
Athenex (ATNX) United States $1.376B 0.00
Alector (ALEC) United States $1.362B 0.00
Sangamo Therapeutics (SGMO) United States $1.352B 0.00
Innoviva (INVA) United States $1.308B 3.85
Arvinas (ARVN) United States $1.297B 0.00
Coherus BioSciences (CHRS) United States $1.273B 0.00
Principia Biopharma (PRNB) United States $1.226B 0.00
Orchard Therapeutics (ORTX) United Kingdom $1.151B 0.00
Zealand Pharma (ZLDPF) Denmark $1.129B 0.00
WAVE Life Sciences (WVE) Singapore $1.109B 0.00
Zealand Pharma (ZEAL) Denmark $1.046B 0.00
Fate Therapeutics (FATE) United States $1.033B 0.00
Precision BioSciences (DTIL) United States $0.998B 0.00
Pharming Group (PHGUF) Netherlands $0.968B 0.00
ZIOPHARM Oncology Inc (ZIOP) United States $0.934B 0.00
Vanda Pharmaceuticals (VNDA) United States $0.932B 7.83
Codexis (CDXS) United States $0.909B 0.00
Achillion Pharmaceuticals (ACHN) United States $0.864B 0.00
BAVARIAN NORDIC (BVNRY) Denmark $0.846B 0.00
Intellia Therapeutics (NTLA) United States $0.836B 0.00
Vericel (VCEL) United States $0.833B 310.50
MiMedx (MDXG) United States $0.821B 0.00
Anika Therapeutics (ANIK) United States $0.820B 26.61
Twist Bioscience (TWST) United States $0.813B 0.00
Heska (HSKA) United States $0.749B 191.46
Adverum Biotechnologies (ADVM) United States $0.738B 0.00
Revance Therapeutics (RVNC) United States $0.736B 0.00
ANI Pharmaceuticals (ANIP) United States $0.718B 12.25
DBV Technologies S.A (DBVT) France $0.717B 0.00
UROGEN PHARMA (URGN) United States $0.685B 0.00
Cara Therapeutics (CARA) United States $0.671B 0.00
Mesoblast (MESO) Australia $0.665B 0.00
Cellectis S.A (CLLS) France $0.623B 0.00
GENFIT S.A (GNFT) France $0.596B 0.00
AC Immune SA (ACIU) Switzerland $0.593B 13.72
Autolus Therapeutics (AUTL) United Kingdom $0.592B 0.00
Basilea Pharmaceutica AG (BPMUF) Switzerland $0.590B 0.00
Kadmon Holdings (KDMN) United States $0.584B 0.00
Sorrento Therapeutics (SRNE) United States $0.579B 0.00
BioDelivery Sciences (BDSI) United States $0.576B 0.00
PHARMA MAR SA (PHMMF) Spain $0.570B 0.00
Retrophin (RTRX) United States $0.570B 0.00
Intra-Cellular Therapies (ITCI) United States $0.564B 0.00
Cytokineticsorporated (CYTK) United States $0.557B 0.00
Agenus (AGEN) United States $0.537B 0.00
Clovis Oncology (CLVS) United States $0.527B 0.00
Lexicon Pharmaceuticals (LXRX) United States $0.518B 3.58
Stemline Therapeutics (STML) United States $0.517B 0.00
OXFORD BIOMEDCL (OXBDF) United Kingdom $0.514B 0.00
Prothena (PRTA) Ireland $0.513B 0.00
Dynavax Technologies (DVAX) United States $0.478B 0.00
Sinovac Biotech (SVA) China $0.460B 0.00
Bellus Health (BLU) Canada $0.402B 0.00
Merus (MRUS) Netherlands $0.381B 0.00
AnaptysBio (ANAB) United States $0.380B 0.00
Arcus Biosciences (RCUS) United States $0.377B 0.00
AMAG Pharmaceuticals (AMAG) United States $0.375B 0.00
Xenon Pharmaceuticals (XENE) Canada $0.361B 0.00
Cellular Biomedicine (CBMG) United States $0.337B 0.00
PDL BioPharma (PDLI) United States $0.337B 8.43
OSMOTICA PHARM (OSMT) United States $0.335B 0.00
Avid Bioservices (CDMO) United States $0.326B 0.00
Gritstone Oncology (GRTS) United States $0.325B 0.00
Starpharma Holdings (SPHRY) Australia $0.320B 0.00
Puma Biotechnology (PBYI) United States $0.307B 0.00
Kindred Biosciences (KIN) United States $0.303B 0.00
Geron (GERN) United States $0.302B 0.00
Kamada (KMDA) Israel $0.297B 8.67
CytomX Therapeutics (CTMX) United States $0.286B 0.00
Compugen (CGEN) Israel $0.276B 0.00
Cue Biopharma (CUE) United States $0.269B 0.00
Albireo Pharma (ALBO) United States $0.264B 0.00
Seres Therapeutics (MCRB) United States $0.257B 0.00
ADMA Biologics Inc (ADMA) United States $0.256B 0.00
Scholar Rock Holding (SRRK) United States $0.252B 0.00
MannKind (MNKD) United States $0.250B 0.00
Inovio Pharmaceuticals (INO) United States $0.239B 0.00
Syndax Pharmaceuticals (SNDX) United States $0.236B 0.00
Sutro Biopharma (STRO) United States $0.233B 0.00
Aeglea BioTherapeutics (AGLE) United States $0.228B 0.00
Spero Therapeutics (SPRO) United States $0.228B 0.00
ChromaDex (CDXC) United States $0.228B 0.00
Biofrontera AG (BFRA) Germany $0.226B 0.00
XOMA (XOMA) United States $0.223B 0.00
Theratechnologies (THTX) Canada $0.221B 0.00
Exicure (XCUR) United States $0.220B 0.00
Protagonist Therapeutics (PTGX) United States $0.209B 0.00
Athersys (ATHX) United States $0.208B 0.00
Senesco Technologies (ELOX) United States $0.205B 0.00
Mersana Therapeutics (MRSN) United States $0.203B 0.00
POXEL SA FRANCE (PXXLF) France $0.203B 0.00
Syros Pharmaceuticals (SYRS) United States $0.195B 0.00
Pieris Pharmaceuticals (PIRS) United States $0.188B 0.00
IVERIC Bio (ISEE) United States $0.183B 0.00
Proteostasis Therapeutics (PTI) United States $0.182B 0.00
Cerecor (CERC) United States $0.176B 0.00
Affimed (AFMD) Germany $0.174B 0.00
Dyadic (DYAI) United States $0.165B 0.00
Alcobra (ARCT) United States $0.162B 0.00
EYEPOINT PHARMACEUTICALS, INC (EYPT) United States $0.162B 0.00
ARAVIVE, INC (ARAV) United States $0.157B 0.00
Aquinox Pharmaceuticals (NLTX) United States $0.156B 0.00
NantKwest (NK) United States $0.155B 0.00
VBI Vaccines (VBIV) United States $0.154B 0.00
Abeona Therapeutics (ABEO) United States $0.153B 0.00
Bicycle Therapeutics (BCYC) United Kingdom $0.149B 0.00
Five Prime Therapeutics (FPRX) United States $0.142B 0.00
Fortress Biotech (FBIO) United States $0.141B 0.00
Aptinyx (APTX) United States $0.139B 0.00
TELA Bio (TELA) United States $0.136B 0.00
Newron Pharmaceuticals SpA (NWPHF) Italy $0.134B 0.00
Arsanis (XFOR) United States $0.133B 0.00
Northwest Biotherapeutics (NWBO) United States $0.132B 0.00
Nymox Pharmaceutical (NYMX) Canada $0.132B 0.00
Prometic Life Sciences (LMNL) Canada $0.131B 0.00
Arbutus Biopharma (ABUS) Canada $0.130B 0.00
Enzo Biochem (ENZ) United States $0.130B 0.00
Windtree Therapeutics (WINT) United States $0.129B 0.00
Celyad SA (CYAD) Belgium $0.125B 0.00
SESEN BIO, INC (SESN) United States $0.124B 0.00
Nicox SA (NICXF) France $0.122B 0.00
AVEO Pharmaceuticals (AVEO) United States $0.121B 0.00
Adaptimmune Therapeutics (ADAP) United Kingdom $0.117B 0.00
Novavax (NVAX) United States $0.116B 0.00
Menlo Therapeutics (MNLO) United States $0.104B 0.00
Paratek Pharmaceuticals (PRTK) United States $0.102B 0.00
Verastem (VSTM) United States $0.098B 0.00
Strongbridge Biopharma (SBBP) United States $0.098B 2.62
PHASEBIO PHARMA (PHAS) United States $0.096B 0.00
Aduro Biotech (ADRO) United States $0.093B 0.00
Antibe Therapeutics (ATBPF) Canada $0.093B 0.00
Emmaus Life Sciences (EMMA) United States $0.092B 0.00
Adocia (ADOCY) France $0.086B 0.00
OvaScience (MLND) United States $0.084B 0.00
Acorda Therapeutics (ACOR) United States $0.082B 0.00
VTv Therapeutics (VTVT) United States $0.081B 0.00
Liquidia Technologies (LQDA) United States $0.076B 0.00
ASLAN Pharmaceuticals (ASLN) Singapore $0.076B 0.00
ANIXA BIOSCIENCES INC (ANIX) United States $0.076B 0.00
Synlogic (SYBX) United States $0.075B 0.00
Selecta Biosciences (SELB) United States $0.073B 0.00
Vaccinex (VCNX) United States $0.071B 0.00
Catabasis Pharmaceuticals (CATB) United States $0.068B 0.00
Clearside Biomedical (CLSD) United States $0.067B 0.00
Trevena (TRVN) United States $0.065B 0.00
Prima BioMed (IMMP) Australia $0.064B 0.00
Organovo Holdings (ONVO) United States $0.064B 0.00
Catalyst Biosciences (CBIO) United States $0.063B 0.00
Pluristem Therapeutics (PSTI) Israel $0.060B 0.00
Spring Bank Pharmaceuticals (SBPH) United States $0.057B 0.00
Merrimack Pharmaceuticals (MACK) United States $0.057B 0.00
NewLink Genetics (NLNK) United States $0.057B 0.00
Applied Genetic Technologies (AGTC) United States $0.052B 0.00
Idera Pharmaceuticals (IDRA) United States $0.052B 0.00
Curis (CRIS) United States $0.052B 0.00
Checkpoint Therapeutics (CKPT) United States $0.048B 0.00
AquaBounty Technologies (AQB) United States $0.048B 0.00
Aridis Pharmaceuticals (ARDS) United States $0.045B 0.00
Vascular Biogenics (VBLT) Israel $0.044B 0.00
AIT Therapeutics (XAIR) United States $0.044B 0.00
Orgenesis (ORGS) United States $0.044B 2.83
Celldex Therapeutics (CLDX) United States $0.041B 0.00
Alimera Sciences (ALIM) United States $0.037B 0.00
Sunesis Pharmaceuticals (SNSS) United States $0.036B 0.00
Stellar Biotechnologies (EDSA) Canada $0.035B 0.00
DiaMedica Therapeutics (DMAC) United States $0.034B 0.00
Evogene (EVGN) Israel $0.033B 0.00
Celsion (CLSN) United States $0.033B 0.00
Oncobiologics (OTLK) United States $0.031B 0.00
Bionano Genomics (BNGO) United States $0.030B 0.00
VIVUS (VVUS) United States $0.029B 0.00
Fibrocell Science Inc (FCSC) United States $0.029B 16.61
Apricus Biosciences (SEEL) United States $0.029B 0.00
Aptevo Therapeutics (APVO) United States $0.027B 0.00
Caladrius Biosciences (CLBS) United States $0.027B 0.00
BioCardia (BCDA) United States $0.027B 0.00
INNOVATE BIOPHARMACEUTICALS, INC (INNT) United States $0.026B 0.00
Novogen (KZIA) Australia $0.026B 0.00
Entera Bio (ENTX) Israel $0.026B 0.00
Soligenix (SNGX) United States $0.024B 0.00
Aerpio Pharmaceuticals (ARPO) United States $0.023B 0.00
Unum Therapeutics (UMRX) United States $0.021B 0.00
CollPlant Holdings (CLGN) Israel $0.019B 0.00
VistaGen Therapeutics (VTGN) United States $0.019B 0.00
Signal Genetics (MGEN) United States $0.018B 0.00
Pulmatrix (PULM) United States $0.017B 0.00
AEterna Zentaris (AEZS) United States $0.017B 0.00
Aytu Bioscience (AYTU) United States $0.015B 0.00
TOCAGEN INC (TOCA) United States $0.015B 0.00
IMMURON (IMRN) Australia $0.014B 0.00
Advaxis (ADXS) United States $0.013B 0.00
Prana Biotechnology (ATHE) Australia $0.013B 0.00
MYOS RENS Technology (MYOS) United States $0.013B 0.00
Titan Pharmaceuticals (TTNP) United States $0.011B 0.00
TrovaGene (TROV) United States $0.010B 0.00
Cyclacel Pharmaceuticals (CYCC) United States $0.010B 0.00
TRACON Pharmaceuticals (TCON) United States $0.010B 0.00
Cesca Therapeutics (THMO) United States $0.008B 0.00
Genetic Technologies (GENE) Australia $0.008B 0.00
Cleveland BioLabs (CBLI) United States $0.007B 0.00
Benitec Biopharma (BNTC) Australia $0.007B 0.00
Neuralstem (SNCA) United States $0.004B 0.00